A61K 31/025
Carbocyclic
Official title: carbocyclic
A61K31/025 (Carbocyclic) appears on 199 US grants and 257 published applications in this corpus.
Search patents in A61K- Granted patents
- 199
- Published applications
- 257
- Assignees
- 172
- Inventors
- 539
- Latest grant
- 8 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 3 | 0 |
| 1977 | 2 | 0 |
| 1978 | 1 | 0 |
| 1979 | 2 | 0 |
| 1980 | 1 | 0 |
| 1981 | 0 | 0 |
| 1982 | 1 | 0 |
| 1983 | 0 | 0 |
| 1984 | 4 | 0 |
| 1985 | 1 | 0 |
| 1986 | 1 | 0 |
| 1987 | 0 | 0 |
| 1988 | 0 | 0 |
| 1989 | 2 | 0 |
| 1990 | 1 | 0 |
| 1991 | 2 | 0 |
| 1992 | 3 | 0 |
| 1993 | 1 | 0 |
| 1994 | 1 | 0 |
| 1995 | 5 | 0 |
| 1996 | 5 | 0 |
| 1997 | 11 | 0 |
| 1998 | 4 | 0 |
| 1999 | 3 | 0 |
| 2000 | 2 | 0 |
| 2001 | 4 | 1 |
| 2002 | 4 | 6 |
| 2003 | 0 | 5 |
| 2004 | 1 | 12 |
| 2005 | 2 | 2 |
| 2006 | 3 | 5 |
| 2007 | 1 | 7 |
| 2008 | 4 | 4 |
| 2009 | 6 | 7 |
| 2010 | 1 | 10 |
| 2011 | 1 | 8 |
| 2012 | 0 | 7 |
| 2013 | 7 | 10 |
| 2014 | 4 | 11 |
| 2015 | 8 | 10 |
| 2016 | 7 | 17 |
| 2017 | 7 | 16 |
| 2018 | 19 | 30 |
| 2019 | 22 | 17 |
| 2020 | 10 | 16 |
| 2021 | 7 | 17 |
| 2022 | 3 | 9 |
| 2023 | 7 | 14 |
| 2024 | 7 | 7 |
| 2025 | 6 | 5 |
| 2026 | 2 | 4 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Pharmaceutical composition comprising mitotane administered orally for treatment of adrenocortical carcinoma and Cushing's syndrome8 Sep 2026US 12,728,103 B2
- Energetic cancer stem cells (E-CSCS): a new hyper-metabolic and proliferative tumor cell phenotype, driven by mitochondrial energy17 Feb 2026US 12,553,092 B2Lunella Biotech, Inc.
- Deuterated analogs of etifoxine, their derivatives and uses thereof7 Oct 2025US 12,433,896 B2Gaba Therapeutics Inc.
- Specifically meso-substituted porphyrins and chlorins for photodynamic therapy2 Sep 2025US 12,403,127 B2Biolitec Unternehmensbeteiligungs II AG
- Glucocorticoid receptor modulators to treat pancreatic cancer29 Jul 2025US 12,370,175 B2Corcept Therapeutics, Inc.
- Bicyclic compounds as inactivators of oat and gaba-at10 Sep 2026US 2026/0265177 A1Northwestern University
- Compositions comprising an urolithin compound16 Jul 2026US 2026/0200887 A1Amazentis SA
- Computational methods to determine relationships between datasets8 Jan 2026US 2026/0011402 A1Cybele Microbiome, Inc.
- Methods of inducing anesthesia1 Jan 2026US 2026/0000638 A1The Regents of the University of California
- Glucocorticoid receptor modulators to treat pancreatic cancer9 Oct 2025US 2025/0312312 A1Corcept Therapeutics, Inc.
Most cited
By later US patents
- Method of assisting normal breathing in a mammal having a lung disorder100US 5,824,703 ASynthetic Blood International, Inc. · 1998
- Nonaqueous fluorinated drug delivery vehicle suspensions89US 5,518,731 AAllergan, Inc. · 1996
- Method for responding to an emergency event83US 5,960,337 ATrimble Navigation Limited · 1999
- Small particle liposome aerosols for delivery of anti-cancer drugs74US 6,090,407 AResearch Development Foundation · 2000
- Partial liquid breathing of fluorocarbons60US 5,490,498 AAlliance Pharmaceutical Corp. · 1996